TrialJournal of pharmacokinetics and pharmacodynamics2018

Joint longitudinal model development: application to exposure-response modeling of ACR and DAS scores in rheumatoid arthritis patients treated with sirukumab.

Chuanpu Hu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.